Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study.

@article{WILLIAMSHERMAN2009EfficacyAS,
  title={Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study.},
  author={DEBORA E. WILLIAMS-HERMAN and Jeremy T Johnson and Rujun Teng and Edmund Luo and Michael J Davies and Keith D. Kaufman and Barry J. Goldstein and John M. Amatruda},
  journal={Current medical research and opinion},
  year={2009},
  volume={25 3},
  pages={569-83}
}
OBJECTIVE To assess the 54-week efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes and inadequate glycemic control (HbA(1c) 7.5-11%) on diet and exercise. METHODS AND MATERIALS This was multinational study conducted at 140 clinical sites in 18 countries. Following an initial 24-week, double-blind, placebo-controlled period, patients entered a double-blind continuation period for an additional 30 weeks. Following the week 24… CONTINUE READING
57 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 57 extracted citations

Similar Papers

Loading similar papers…